Payne D K, Fuseler J W, Owens M W
Department of Medicine, LSU, Shreveport.
Inflammation. 1994 Aug;18(4):407-17. doi: 10.1007/BF01534438.
This study examined the hypothesis that tumor cells metastatic to the pleura secrete a soluble factor(s) that directly increases endothelial cell permeability. Nitrocellulose filters were endothelialized with bovine pulmonary artery endothelial cells and exposed to conditioned media from either human lung adenocarcinoma (Calu-3), human lung squamous cell carcinoma (SK-MES-1), or control media for 16 h. The diffusional permeability (Pd x 10(-5) cm/sec) to [14C]albumin was then determined for each monolayer with Ussing-type chambers. Both adenocarcinoma conditioned media (ACCM) and squamous cell carcinoma conditioned media (SCCM) caused a two- to threefold increase in endothelial monolayer permeability. The addition of indomethacin (10 micrograms/ml) blocked the observed permeability increase in ACCM but not in SCCM, suggesting that the increase in permeability by ACCM was secondary to the production of prostaglandins. To confirm this, a variety of prostanoids previously shown to be produced by the Calu-3 cell line were added directly to the endothelial monolayer. Prostaglandin F2 alpha (PGF2 alpha) in both low (10 ng/ml) and high (100 ng/ml) concentrations for 16 h resulted in a three- to fourfold increase in permeability. Prostaglandin E2 (PGE2) resulted in a small increase in [14C]albumin permeability but only at high concentrations (100 ng/ml). PGF2 alpha production by the two tumor cell lines was measured using radioimmunoassay. Baseline adenocarcinoma production of PGF2 alpha was 117.5 pmol/10(6) cells and fell to 24.2 pmol/10(6) cells hours following incubation with indomethacin. The decrease in PGF2 alpha occurred in parallel with the changes in permeability. Concomitant, reversible changes in cell shape and F-actin distribution were detected in endothelial cells exposed to ACCM. No significant production of PGF2 alpha by the squamous cell carcinoma cell line was detected. These results suggest that both adenocarcinoma and squamous cell carcinoma secrete a soluble factor(s) that directly increases endothelial cell permeability to albumin and that in the case of adenocarcinoma this soluble factor may be a prostanoid such as PGF2 alpha.
转移至胸膜的肿瘤细胞分泌一种可溶性因子,该因子可直接增加内皮细胞通透性。用牛肺动脉内皮细胞使硝酸纤维素滤膜内皮化,并将其暴露于来自人肺腺癌(Calu-3)、人肺鳞状细胞癌(SK-MES-1)的条件培养基或对照培养基中16小时。然后用尤斯灌流小室测定每个单层对[14C]白蛋白的扩散通透性(Pd×10(-5)厘米/秒)。腺癌条件培养基(ACCM)和鳞状细胞癌条件培养基(SCCM)均使内皮单层通透性增加了两到三倍。加入吲哚美辛(10微克/毫升)可阻断ACCM中观察到的通透性增加,但对SCCM无效,这表明ACCM引起的通透性增加继发于前列腺素的产生。为证实这一点,将先前显示由Calu-3细胞系产生的多种前列腺素直接添加到内皮单层中。低浓度(10纳克/毫升)和高浓度(100纳克/毫升)的前列腺素F2α(PGF2α)作用16小时后,通透性增加了三到四倍。前列腺素E2(PGE2)仅在高浓度(100纳克/毫升)时使[14C]白蛋白通透性略有增加。用放射免疫分析法测定了两种肿瘤细胞系的PGF2α产生情况。腺癌PGF2α的基础产量为117.5皮摩尔/10(6)个细胞,与吲哚美辛孵育数小时后降至24.2皮摩尔/10(6)个细胞。PGF2α的减少与通透性变化平行。在暴露于ACCM的内皮细胞中检测到细胞形状和F-肌动蛋白分布的伴随性、可逆性变化。未检测到鳞状细胞癌细胞系有明显的PGF2α产生。这些结果表明,腺癌和鳞状细胞癌均分泌一种可溶性因子,该因子可直接增加内皮细胞对白蛋白的通透性,且就腺癌而言,这种可溶性因子可能是一种前列腺素,如PGF2α。